These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4920473)

  • 1. Localization of streptolydigin resistant mutation in E. coli chromosome and effect of streptolydigin on T2 phage development in stl-r and stl-s strains of E. coli.
    Sokolova EV; Ovadis MI; Gorlenko ZM; Khesin RB
    Biochem Biophys Res Commun; 1970 Nov; 41(4):870-6. PubMed ID: 4920473
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifamycin-resistant mutation in E. coli: effect of rifamycin on DNA-dependent RNA polymerase and on R17 phage growth.
    Igarashi SJ
    Can J Biochem; 1972 Feb; 50(2):128-35. PubMed ID: 4552309
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of R factors on rifampicin resistance in E. coli.
    Romero E; Riva S; Fietta AM; Silvestri LG
    Nat New Biol; 1971 Nov; 234(45):56-8. PubMed ID: 4942897
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of M13 phage synthesis by rifampicin in some rifampicin-resistant Escherichia coli mutants.
    Mitra S
    Virology; 1972 Nov; 50(2):422-30. PubMed ID: 4564525
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutations affecting RNA polymerase associated with rifampicin resistance in Escherichia coli.
    Ezekiel DH; Hutchins JE
    Nature; 1968 Oct; 220(5164):276-7. PubMed ID: 4879326
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of host RNA polymerase for lambda phage development.
    Takeda Y; Oyama Y; Nakajima K; Yura T
    Biochem Biophys Res Commun; 1969 Aug; 36(4):533-8. PubMed ID: 4390186
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic complementation between Escherichia coli RNA polymerase mutants.
    Jacobson A; Gillespie D
    Biochem Biophys Res Commun; 1971 Sep; 44(5):1030-40. PubMed ID: 4946184
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the functions of the RNA polymerase components by means of mutations.
    Khesin RB; Gorlenko ZM; Shemyakin MF; Stvolinsky SL; Mindlin SZ; Ilyina TS
    Mol Gen Genet; 1969; 105(3):243-61. PubMed ID: 4904981
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth of bacteriophage f2 in E. coli treated with rifampicin.
    Fromageot HP; Zinder ND
    Proc Natl Acad Sci U S A; 1968 Sep; 61(1):184-91. PubMed ID: 4880606
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of rifampin on the growth of bacteriophage T5.
    Beckman LD; Witonsky P; McCorguodale DJ
    J Virol; 1972 Aug; 10(2):179-86. PubMed ID: 4561405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rifampin on the development of ribonucleic acid bacteriophage Q .
    Passent J; Kaesberg P
    J Virol; 1971 Sep; 8(3):286-92. PubMed ID: 4940929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant of E. coli containing an altered DNA-dependent RNA polymerase.
    Tocchini-Valentini GP; Marino P; Colvill AJ
    Nature; 1968 Oct; 220(5164):275-6. PubMed ID: 4879325
    [No Abstract]   [Full Text] [Related]  

  • 13. Pleiotropic effects of a rifampicin-resistant mutation in E. coli.
    Romero E; Riva S; Berti M; Fietta AM; Silvestri LG
    Nat New Biol; 1973 Dec; 246(155):225-8. PubMed ID: 4587242
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetical analysis of rifampicin resistant mutants of E. coli K 12.
    Mindlin SZ; Ilyina TS; Voeykova TA; Velkov VV
    Mol Gen Genet; 1972; 115(2):115-21. PubMed ID: 4554472
    [No Abstract]   [Full Text] [Related]  

  • 15. [Properties of dominance of various mutations conferring rifomycin resistance in E. coli K12].
    Babinet C
    Biochimie; 1971; 53(4):507-16. PubMed ID: 4942124
    [No Abstract]   [Full Text] [Related]  

  • 16. A new RNA synthesis mutant of E. coli.
    Patterson D; Weinstein M; Marshall S; Gillespie D
    Biochem Genet; 1971 Dec; 5(6):563-78. PubMed ID: 5000592
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation and characterization of rifampin-resistant and streptolydigin-resistant mutants of Bacillus subtilis with altered sporulation properties.
    Sonenshein AL; Cami B; Brevet J; Cote R
    J Bacteriol; 1974 Oct; 120(1):253-65. PubMed ID: 4370705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T3 and T7 phages].
    Matsuo H; Fujisawa H
    Tanpakushitsu Kakusan Koso; 1972; 17():Suppl:245-51. PubMed ID: 4557707
    [No Abstract]   [Full Text] [Related]  

  • 19. Limited production of R17 ribonucleic acid phage in the presence of rifampin.
    Rothwell JD; Yamazaki H
    Biochemistry; 1972 Aug; 11(18):3333-8. PubMed ID: 4560262
    [No Abstract]   [Full Text] [Related]  

  • 20. Ribonucleic acid bacteriophage release: requirement for host-controlled protein synthesis.
    Engelberg H; Soudry E
    J Virol; 1971 Sep; 8(3):257-64. PubMed ID: 4107540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.